Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats

Pharmacology

Volumn 81, Issue 1, 2007, Pages 41-49

  Leija Salas, Alfonso ^a   Díaz Montezuma, Tania ^a   Garrido Fariña, German ^b   Reyes Esparza, Jorge ^a   Rodríguez Fragoso, Lourdes ^a,c  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c NONE   (Mexico)

Author keywords

Collagen; Extracellular matrix; Fibrosis; Genistein; Hepatic stellate cell

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; COLLAGEN FIBER; COLLAGEN TYPE 1; GENISTEIN; MATRIGEL; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG SCREENING; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FIBER; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; LIVER HISTOLOGY; LIVER LEVEL; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; STELLATE CELL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CARBON TETRACHLORIDE; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; GENISTEIN; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDE HYDROLASES; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; URINARY PLASMINOGEN ACTIVATOR;

EID: 36248936506     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107968     Document Type: Article

References (47)

1. Friedman SL: Liver fibrosis - from bench to bedside. J Hepatol 2003;38(suppl 1):S38-S53.
2. Jaeschke H: Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997;273:G602-G611.
3. Pinzani M, Marra F: Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001;21:397-416.
4. Afdhal NH, Nunes D: Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-1174.
5. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
6. Rockey DC: The cell and molecular biology of hepatic fibrogenesis: clinical and therapeutic implications. Clin Liver Dis 2000;4:319-355.
7. Safadi R, Friedman SL: Hepatic fibrosis - role of hepatic stellate cell activation. Med Gen Med 2002;4:27.
8. Mabuchi A, Mullaney I, Sheard P, Hessian P, Zimmermann A, Senoo H, Wheatley AM: Role of hepatic stellate cells in the early phase of liver regeneration in rat: formation of tight adhesion to parenchymal cells. Comp Hepatol 2004;1:S29-S37.
9. Reeves HL, Friedman SL: Activation of hepatic stellate cells - a key issue in liver fibrosis. Front Biosci 2002;7:d808-d826.
10. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R: Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003;124:147-159.
11. Marra F: Chemokines in liver inflammation and fibrosis. Front Biosci 2002;7:d1899-d1914.
12. Polkowski K, Mazurek AP: Biological properties of genistein: a review of in vitro and in vivo data. Acta Pol Pharm 2000;57:135-155.
13. Barnes S, Boersma B, Patel R, Kirk M, Darley-Usmar VM, Kim H, Xu J: Isoflavonoids and chronic disease: mechanisms of action. Biofactors 2000;12:209-215.
14. Arjmandi BH, Smith BJ: Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 2002;13:130-137.
15. Weggemans RM, Trautwein EA: Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 2003;57:940-946.
16. Wang HK: The therapeutic potential of flavonoids. Expert Opin Investig Drugs 2000;9:2103-2119.
17. Atherton KM, Mutch E, Ford D: Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity. Biochem Pharmacol 2006;72:624-631.
18. Lee YM, Choi JS, Kim MH, Jung MH, Lee YS, Song J: Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition 2006;22:956-964.
19. Caldarelli A, Diel P, Vollmer G: Effect of phytoestrogens on gene expression of carbonic anhydrase II in rat uterus and liver. J Steroid Biochem Mol Biol 2005;97:251-256.
20. Kang LP, Qi LH, Zhang JP, Shi N, Zhang M, Wu TM, Chen J: Effect of genistein and quercetin on proliferation, collagen synthesis, and type I procollagen mRNA levels of rat hepatic stellate cells. Acta Pharmacol Sin 2001;22:793-806.
21. Badria FA, Dawidar AA, Houssen WE, Shier WT: In vitro study of flavonoids, fatty acids, and steroids on proliferation of rat hepatic stellate cells. Z Naturforsch C 2005;60:139-142.
22. Qi LH, Kang LP, Zhang JP, Shi N, Zhang M, Wu TM: Antifibrotic effects of genistein and quercetin in vitro. Yao Xue Xue Bao 2001;36:648-651.
23. Leija-Salas A, Ocampo G, Garrido-Fariña G, Reyes-Esparza J, Rodríguez-Fragoso L: Genistein decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the rat. Ann Hepatol 2007;6:45-47.
24. Committee on Care and Use of Laboratory Animals of the Institute for Laboratory Animal Resources, Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Publication 86-23, rev. Washington, National Academy Press, 1996.
25. Rojkind M: Inhibition of liver fibrosis by L-azetidine-2- carboxylic acid in rats treated with carbon tetrachloride. J Clin Invest 1973;52:2451-2456.
26. 14C in collagen and noncollagenous protein. Anal Biochem 1974;57:1-7.
27. Nethery A, Lyons JG, O'Grady RL: A spectrophotometric collagenase assay. Anal Biochem 1986;159:390-395.
28. Gressner AM, Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99.
29. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005;115:209-218.
30. Giannelli G, Quaranta V, Antonaci S: Tissue remodelling in liver diseases. Histol Histopathol 2003;18:1267-1274.
31. Senties-Gomez MD, Galvez-Gastelum FJ, Meza-Garcia E, Armendariz-Borunda J: Hepatic fibrosis: role of matrix metalloproteases and TGFbeta. Gac Med Mex 2005;141:315-322.
32. Arthur MJ: Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002;122:1303-1313.
33. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H: Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002;36:850-860.
34. Fajardo I, Diez E, Rodriguez-Nieto S, Rodriguez-Caso C, Quesada AR, Sanchez-Jimenez F, Medina MA: Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells. Anticancer Res 2000;20:1691-1694.
35. Garcia de Veas R, Schweigerer L, Medina MA: Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. Eur J Cancer 1998;34:1736-1740.
36. Santibanez JF, Navarro A, Martinez J: Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 1997;17:1199-1204.
37. Leyland H, Gentry J, Arthur MJ, Benyon RC: The plasminogen-activating system in hepatic stellate cells. Hepatology 1996;24:1172-1178.
38. Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A: Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. J Hepatol 1999;31:703-711.
39. Liu XJ, Yang L, Mao YQ, Wang Q, Huang MH, Wang YP, Wu HB: Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J Gastroenterol 2002;8:739-745.
40. Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H: Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth. J Lab Clin Med 2000;135:406-412.
41. Chodon D, Banu SM, Padmavathi R, Sakthisekaran D: Inhibition of cell proliferation and induction of apoptosis by genistein in experimental hepatocellular carcinoma. Mol Cell Biochem 2007;297:73-80.
42. Geis RB, Diel P, Degen GH, Vollmer G: Effects of genistein on the expression of hepatic genes in two rat strains (Sprague-Dawley and Wistar). Toxicol Lett 2005;157:21-29.
43. Liu X, Huang M, Cheng N, Xiao W, Wang Y: Effects of genistein on the fenestrae, proliferation and nitric oxide synthesis of liver sinusoidal endothelial cells from carbon tetrachloride-induced experimental hepatic fibrosis rats. Zhonghua Gan Zang Bing Za Zhi 2002;10:200-203.
44. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA: Antioxidant activity of phytoestrogenic isoflavonas. Free Rad Res 1997;26:63-70.
45. Aneja R, Upadhyaya G, Prakash S, Dass SK, Chandra R: Ameliorating effect of phytoestrogens on CCl4-induced oxidative stress in the livers of male Wistar rats. Artif Cells Blood Substit Immobil Biotechnol 2005;33:201-213.
46. Griffith OW: Mechanism of action, metabolism and toxicity of buthionine and its higher homologies, potent inhibitors of glutathione synthesis. J Biol Chem 1982;257:13704-13712.
47. Seelig GF, Meister A: Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 1985;113:379-390.